October 2020 FAQs Update: What evidence supports the use of direct-acting oral anticoagulants in patients with cancer-related VTE? How should unfractionated heparin be monitored in patients transitioning from oral factor Xa inhibitors? What is the role of dapagliflozin for treatment of heart failure?